Wednesday , August 22 2018
Home / Conditions (page 60)



“Synjardy” Approved for Type 2 Diabetes

Single-tablet approach hoped to boost treatment compliance and help patients better manage condition.. Synjardy contains empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a biguanide. It is not for the treatment of type 1 diabetes or diabetic ketoacidosis. The drug label contains a boxed warning on the risk of …

Read More »